Filing Flows › Revvity (RVTY) › How it makes money
How Revvity (RVTY) makes money
Revvity (RVTY) made $729M of revenue in the third quarter 2026 (Q3 2026), +4% from a year earlier. Life Sciences brought in $380M (52%); Diagnostics brought in $349M (48%). Of every dollar of revenue, 11¢ was left as operating profit, 9¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Life Sciences | $380M | 52.1% | — | +11% |
| Diagnostics | $349M | 47.9% | — | -2% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $729M | 100.0% |
| Operating profit | $77.4M | 10.6% |
| Income tax | $15.1M | 2.1% |
| Net earnings | $62.3M | 8.5% |
| Operating cash flow | $167M | 22.9% |
| Free cash flow | $152M | 20.9% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $729M | +4% |
| Q2 2026 | $730M | +1% |
| Q1 2026 | $711M | +7% |
| Q4 2025 | $772M | +6% |
| Q3 2025 | $699M | +2% |
| Q2 2025 | $720M | +4% |
| Q1 2025 | $665M | +2% |
From Revvity's 8-K filed Nov 3, 2026 (on EDGAR).
Questions
How does Revvity make money?
Revvity (RVTY) made $729M of revenue in the third quarter 2026 (Q3 2026), +4% from a year earlier. Life Sciences brought in $380M (52%); Diagnostics brought in $349M (48%). Of every dollar of revenue, 11¢ was left as operating profit, 9¢ was left as net earnings.
What is Revvity's biggest business?
Life Sciences: $380M in the third quarter 2026, 52% of revenue, +11% from a year earlier.
What is Revvity's profit margin?
Net earnings were $62.3M, 8.5% of revenue, in the third quarter 2026; the operating margin was 10.6%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.